Cargando…
Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
A 32-year-old woman with highly active MS was infected with SARS-CoV-2 while on treatment with rituximab. She recovered and was symptom-free for 21 days before receiving rituximab and IVIg for comorbid hypogammaglobulinemia. Three days after the infusion she redeveloped respiratory symptoms and requ...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992302/ https://www.ncbi.nlm.nih.gov/pubmed/33895693 http://dx.doi.org/10.1016/j.msard.2021.102922 |